Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Carbohydr Polym ; 216: 332-342, 2019 Jul 15.
Article in English | MEDLINE | ID: mdl-31047074

ABSTRACT

Chitosan has received a lot of attention as a carrier for small interfering RNA (siRNA), due to its capacity for complexation and intracellular release of these molecules. However, one of its limitations is its insolubility at neutral pH and the tendency towards aggregation of its nanoparticles in isotonic ionic strength. In this study, a series of amphipathic chitosans were synthesized by varying the degree of acetylation (DA) from ˜2 to ˜30 mol% and the degree of substitution (DS) from 5 to 25%. by tertiary amino groups (DEAE) The results showed that the adjustment of these parameters decreases the interparticle interactions mediated by hydrogen bonding to obtain nanoparticles with improved colloidal stability. siRNA-containing nanoparticles of 100 to 150 nm with low polydispersities (0.15-0.2) and slightly positive zeta potentials (˜+ 5 mV) were resistant to aggregation at pH 7.4 and ionic strength of 150 mM. This resistance to aggregation is provided by changes on the nanoparticle surface and highlights the importance of more organized self-assembly in providing colloidal stability at physiological conditions. Additionally, the PEGylation of the most promising vectors conferred favorable physicochemical properties to nanoparticles. The chitosans and their nanoparticles exhibited low toxicity and an efficient cell uptake, as probed by confocal microscopy of rhodamine labeled vectors. The results provide a new approach to overcome the limited stability of chitosan nanoparticles at physiological conditions and show the potential of these amphipathic chitosans as siRNA carriers.


Subject(s)
Chitosan/analogs & derivatives , Drug Carriers/chemistry , Nanoparticles/chemistry , RNA, Small Interfering/administration & dosage , Surface-Active Agents/chemistry , Acetic Anhydrides/chemistry , Acetylation , Animals , Chitosan/chemical synthesis , Chitosan/metabolism , Chitosan/toxicity , Diethylamines/chemistry , Drug Carriers/chemical synthesis , Drug Carriers/metabolism , Drug Carriers/toxicity , Fluorescence , Fluorescent Dyes/chemistry , Hydrogen-Ion Concentration , Mice , Nanoparticles/metabolism , Nanoparticles/toxicity , Particle Size , Polyethylene Glycols/chemical synthesis , Polyethylene Glycols/chemistry , Polyethylene Glycols/metabolism , Polyethylene Glycols/toxicity , RAW 264.7 Cells , RNA, Small Interfering/chemistry , Rhodamines/chemistry , Surface-Active Agents/chemical synthesis , Surface-Active Agents/metabolism , Surface-Active Agents/toxicity
2.
Cell Biol Int ; 31(3): 235-45, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17123842

ABSTRACT

Mongolian gerbils (Meriones unguiculatus) were grouped into two experimental groups: GEx.01 suffered orchiectomy and after 30 days received doses of testosterone cipionate (T), while GEx.02 received weekly and alternated doses of the anti-androgens cyproterone acetate and flutamide for 30 days, and the animals were then euthanized. Structural evaluation reveals a more intense reduction in epithelial height in GEx.02. Smooth muscle cells (SMC) presented a star-shaped aspect after 30 days of hormonal ablation and basal membrane was shown to be more intensely grooved in GEx.01. In both groups, after hormonal replacement, recovery in epithelial height could be noted and the SMC presented its phenotypes, but an increase in RER was seen, characterizing a modulation from its contractile to secreting phenotype. In conclusion, the prostate presented involution capacity after androgen ablation and the ability to reorganize after hormonal replacement, but events resulting from orchiectomy and subsequent T replacement were shown to be more aggressive to the prostate.


Subject(s)
Androgen Antagonists/administration & dosage , Orchiectomy , Prostate/pathology , Prostatic Hyperplasia/pathology , Testosterone/administration & dosage , Acid Phosphatase , Animals , Cyproterone , Disease Models, Animal , Endoplasmic Reticulum, Rough/ultrastructure , Endothelium/ultrastructure , Flutamide , Gerbillinae , Immunohistochemistry , Male , Microscopy, Electron, Transmission , Orchiectomy/methods , Organ Size/drug effects , Prostate/drug effects , Prostate/growth & development , Prostate/metabolism , Prostatic Hyperplasia/chemically induced , Prostatic Hyperplasia/metabolism , Protein Tyrosine Phosphatases/metabolism , Receptors, Androgen/drug effects , Receptors, Androgen/metabolism , Testosterone/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...